Heterogeneity within T cell memory: Implications for transplant tolerance

Frontiers in Immunology

Volumn 3, Issue MAR, 2012, Pages

  Krummey, Scott M ^a   Ford, Mandy L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Costimulation; Heterologous immunity; Memoryt cells; Transplantation tolerance

Indexed keywords

EID: 84873098245     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00036     Document Type: Article

References (161)

1. Abrams, J. R., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G., Brown, M. J., Weiner, R. S., Birkhofer, M. J., Warner, G. L., Berry, K. K., Linsley, P. S., Krueger, J. G., Ochs, H. D., Kelley, S. L., and Kang, S. (1999). CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103, 1243-1252.
2. Adams, A. B., Durham, M. M., Kean, L., Shirasugi, N., Ha, J., Williams, M. A., Rees, P. A., Cheung, M. C., Mittelstaedt, S., Bingaman, A. W., Archer, D. R., Pearson, T. C., Waller, E. K., and Larsen, C. P. (2001). Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplan-tation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J. Immunol. 167, 1103-1111.
3. Adams, A. B., Williams, M. A., Jones, T. R., Shirasugi, N., Durham, M. M., Kaech, S. M., Wherry, E. J., Onami, T., Lanier, J. G., Kokko, K. E., Pear-son, T. C., Ahmed, R., and Larsen, C. P. (2003). Heterologous immunity provides a potent barrier to trans-plantation tolerance. J. Clin. Invest. 111, 1887-1895.
4. Afzali,B.,Mitchell,P. J.,Scotta,C.,Cana-Van, J., Edozie, F. C., Fazekasova, H., Lord, G. M., John, S., Barber, L. D., Hernandez-Fuentes, M. P., Lechler, R. I., and Lombardi, G. (2011). Relative resistance of human CD4(+) memory T cells to suppres-sion by CD4(+) CD25(+) regula-tory T cells. Am. J. Transplant. 11, 1734-1742.
5. Ahmed, E. B., Daniels, M., Ale-Gre, M. L., and Chong, A. S. (2011a). Bacterial infections, alloim-munity, and transplantation toler-ance. Transplant. Rev. (Orlando). 25, 27-35.
6. Ahmed, E. B., Wang, T., Daniels, M., Alegre, M. L., and Chong, A. S. (2011b). IL-6 induced by Staphylo-coccus aureus infection prevents the induction of skin allograft accep-tance in mice. Am. J. Transplant. 11, 936-946.
7. Ahmed, R., and Gray, D. (1996). Immunological memory and protective immunity: understanding their relation. Science 272, 54-60.
8. Alegre, M. L., Goldstein, D. R., and Chong,A. S. (2008a). Toll-like recep-tor signaling in transplantation. Curr. Opin. Organ Transplant 13, 358-365.
9. Alegre, M. L., Leemans, J., Le Moine, A., Florquin, S., De Wilde,V., Chong,A., and Goldman,M. (2008b). The mul-tiple facets of toll-like receptors in transplantation biology. Transplan-tation 86, 1-9.
10. Amir, A. L., D'Orsogna, L. J., Roelen, D. L., van Loenen, M. M., Hage-Doorn, R. S., de Boer, R., van der Hoorn, M. A., Kester, M. G., Doxi-adis, II, Falkenburg, J. H., Claas, F. H., and Heemskerk, M. H. (2010). Allo-HLA reactivity of virus-specific memory T-cells is common. Blood 115, 3146-3157.
11. Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bach-Mann, M. F., Larsen, C. P., and Ahmed, R. (2009). mTOR regulates memory CD8 T-cell differentiation. Nature 460, 108-112.
12. Araki, Y., Fann, M., Wersto, R., and Weng, N. P. (2008). Histone acety-lation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesoder-min and its targets: perforin and granzyme B). J. Immunol. 180, 8102-8108.
13. Bachmann, M. F., Gallimore, A., Link-Ert, S., Cerundolo, V., Lanzavec-Chia, A., Kopf, M., and Viola, A. (1999). Developmental regulation of Lck targeting to the CD8 corecep-tor controls signaling in naive and memory T cells. J. Exp. Med. 189, 1521-1530.
14. Badell, I. R., Russell, M. C., Thompson, P. W., Turner, A. P., Weaver, T. A., Robertson, J. M., Avila, J. G., Cano, J. A., Johnson, B. E., Song, M., Leop-Ardi, F. V., Swygert, S., Strobert, E. A., Ford, M. L., Kirk, A. D., and Larsen, C. P. (2010). LFA-1-specific therapy prolongs allograft survival in rhe-sus macaques. J. Clin. Invest. 120, 4520-4531.
15. Banerjee, A., Gordon, S. M., Intlekofer, A. M., Paley, M. A., Mooney, E. C., Lindsten, T., Wherry, E. J., and Reiner,S. L. (2010). Cutting edge: the transcription factor eomesoderminenables CD8+ T cells to compete for the memory cell niche. J. Immunol. 185, 4988-4992.
16. Beddoe, T., Chen, Z., Clements, C. S., Ely, L. K., Bushell, S. R., Vivian, J. P., Kjer-Nielsen, L., Pang, S. S., Dun-Stone, M. A., Liu, Y. C., Macdonald, W. A., Perugini, M. A., Wilce, M. C., Burrows, S. R., Purcell, A. W., Tiga-Nis, T., Bottomley, S. P., McCluskey, J., and Rossjohn, J. (2009). Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptor. Immunity 30, 777-788.
17. Blair, D. A., and Lefrancois, L. (2007). Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc. Natl.Acad. Sci. U.S.A. 104, 15045-15050.
18. Bluestone, J. A., St Clair, E. W., and Turka, L. A. (2006). CTLA4Ig: bridg-ing the basic immunology with clinical application. Immunity 24, 233-238.
19. Boor, P. P., Metselaar, H. J., Jonge, S., Mancham, S., van der Laan, L. J., and Kwekkeboom, J. (2011). Human plasmacytoid dendritic cells induce CD8 LAG-3 Foxp3 CTLA-4 regu-latory T cells that suppress allo-reactive memory T cells. Eur. J. Immunol. 41, 1663-1674.
20. Borowski, A. B., Boesteanu, A. C., Mueller, Y. M., Carafides, C., Topham, D. J., Altman, J. D., Jen-Nings, S. R., and Katsikis, P. D. (2007). Memory CD8+ Tcells require CD28 costimulation. J. Immunol. 179, 6494-6503.
21. Bouneaud, C., Garcia, Z., Kourilsky, P., and Pannetier, C. (2005). Lin-eage relationships, homeostasis, and recall capacities of central-and effector-memory CD8 T cells in vivo. J. Exp. Med. 201, 579-590.
22. Brehm,M.A.,Markees,T. G.,Daniels,K. A., Greiner, D. L., Rossini, A. A., and Welsh, R. M. (2003). Direct visual-ization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infec-tions. J. Immunol. 170, 4077-4086.
23. Burrows, S. R., Khanna, R., Burrows, J. M.,and Moss,D. J. (1994). An allore-sponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179, 1155-1161.
24. Burrows, S. R., Silins, S. L., Khanna, R., Burrows, J. M., Rischmueller, M., McCluskey, J., and Moss, D. J. (1997). Cross-reactive memory T cells for Epstein-Barr virus aug-ment the alloresponse to common human leukocyte antigens: degen-erate recognition of major histo-compatibility complex-bound pep-tide by T cells and its role in alloreactivity. Eur. J. Immunol. 27, 1726-1736.
25. Burrows, S. R., Silins, S. L., Moss, D. J., Khanna, R., Misko, I. S., and Argaet, V. P. (1995). T cell recep-tor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompati-bility complex antigen. J. Exp. Med. 182, 1703-1715.
26. Carson, K. R., Focosi, D., Major, E. O., Petrini, M., Richey, E. A., West, D. P., and Bennett, C. L. (2009). Mono-clonal antibody-associated progres-sive multifocal leucoencephalopa-thy in patients treated with ritux-imab, natalizumab, and efalizumab: a review from the research on adverse drug events and reports (RADAR) project. Lancet Oncol. 10, 816-824.
27. Chen, Y., Heeger, P. S., and Valujskikh, A. (2004). In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J. Immunol. 172, 5456-5466.
28. Chevalier, N., Jarrossay, D., Ho, E., Avery, D. T., Ma, C. S., Yu, D., Sal-Lusto, F., Tangye, S. G., and Mackay, C. R. (2011). CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J. Immunol. 186, 5556-5568.
29. Croft, M., Bradley, L. M., and Swain, S. L. (1994). Naive versus mem-ory CD4 T cell response to anti-gen. Memory cells are less depen-dent on accessory cell costimula-tion and can respond to many antigen-presenting cell types includ-ing resting B cells. Immunol. J. 152, 2675-2685.
30. Crotty, S. (2011). Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29, 621-663
31. D'Orsogna, L. J., Roelen,D. L.,Doxiadis, II, and Claas, F. H. (2010). Allore-activity from human viral specific memory T-cells. Transpl. Immunol. 23, 149-155.
32. D'Orsogna, L. J., Roelen, D. L., van der Meer-Prins, E. M., van der Pol, P., Franke-Van Dijk,M. E.,Eikmans,M., Anholts, J., Rossjohn, J., McCluskey, J., Mulder, A., van Kooten, C., Doxi-Adis, II, and Claas, F. H. (2011a). Tis-sue specificity of cross-reactive allo-geneic responses by EBV EBNA3A-specific memory T cells. Transplan-tation 91, 494-500.
33. D'Orsogna, L. J., van Besouw, N. M., van der Meer-Prins, E. M., van der Pol, P., Franke-Van Dijk, M., Zoet, Y. M., van der Slik, A., Weimar, W., van Kooten, C., Mulder, A., Roe-Len, D. L., Doxiadis, II, and Claas, F. H. (2011b). Vaccine-induced allo-HLA-reactive memory T cells in a kidney transplantation candidate. Transplantation 91, 645-651.
34. Durham, M. M., Bingaman, A. W., Adams, A. B., Ha, J., Waitze, S. Y., Pearson, T. C., and Larsen, C. P. (2000). Cutting edge: administra-tion of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tol-erance without cytoreductive condi-tioning. J. Immunol. 165, 1-4.
35. Durrbach, A., Pestana, J. M., Pear-Son, T., Vincenti, F., Garcia, V. D., Campistol, J., Rial, M. C., Flor-Man, S., Block, A., Russo, G. D., Xing, J., Garg, P., and Grinyó, J. (2010). A phase III study of belat-acept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am. J. Transplant. 10, 547-557.
36. Evavold, B. D., Sloan-Lancaster, J., and Allen, P. M. (1993). Tickling the TCR: selective T-cell functions stim-ulated by altered peptide ligands. Immunol. Today 14, 602-609.
37. Falkenburg, W. J., Melenhorst, J. J., van de Meent, M., Kester, M. G., Hom-Brink, P., Heemskerk, M. H., Hage-Doorn, R. S., Gostick, E., Price, D. A., Falkenburg, J. H., Barrett, A. J., and Jedema, I. (2011). Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity. J. Immunol. 187, 2824-2833.
38. Felix, N. J., and Allen, P. M. (2007). Specificity of T-cell alloreactivity. Nat. Rev. Immunol. 7, 942-953.
39. Felix, N. J., Donermeyer, D. L., Horvath, S., Walters, J. J., Gross, M. L., Suri, A., and Allen, P. M. (2007). Allore-active T cells respond specifically to multiple distinct peptide-MHC complexes. Nat. Immunol. 8, 388-397.
40. Ferrer, I. R., Wagener, M. E., Robert-Son, J. M., Turner, A. P., Araki, K., Ahmed, R., Kirk, A. D., Larsen, C. P., and Ford, M. L. (2010). Cutting edge: rapamycin augments pathogen-specific but not graft-reactive CD8+ T Cell Responses. J. Immunol. 185, 2004-2008.
41. Floyd, T. L., Wagener, M. E., Kitchens, W. H., Robertson, J. M., Cheese-man, J. A., Stempora, L., Larsen, C. P., and Ford, M. L. (2011). Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for cos-timulation during recall. J. Immunol. 186, 2033-2041.
42. Ford, M. L., and Evavold, B. D. (2004). Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes. Mol. Immunol. 40, 1019-1025.
43. Ford, M. L., and Larsen, C. P. (2011). Transplantation tolerance: memo-ries that haunt us. Sci. Transl. Med. 3, 86ps22.
44. Goldrath, A. W., Bogatzki, L. Y., and Bevan, M. J. (2000). Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192, 557-564.
45. Grayson, J. M., Murali-Krishna, K., Alt-man, J. D., and Ahmed, R. (2001). Gene expression in antigen-specific CD8+ T cells during viral infection. J. Immunol. 166, 795-799.
46. Grayson, J. M., Zajac, A. J., Altman, J. D., and Ahmed, R. (2000). Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164, 3950-3954.
47. Halloran, P. F. (2004). Immunosup-pressive drugs for kidney trans-plantation. N.Engl.J.Med.351, 2715-2729.
48. Han Lee, E. D., Kemball, C. C., Wang, J., Dong, Y., Stapler, D. C., Hamby, K. M. Jr., Gangappa, S., Newell, K. A., Pearson, T. C., Lukacher, A. E., and Larsen, C. P. (2006). A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am. J. Transplant. 6, 913-922.
49. Hand, T. W., Morre, M., and Kaech, S. M. (2007). Expression of IL-7 recep-tor alpha is necessary but not suf-ficient for the formation of mem-ory CD8 T cells during viral infec-tion. Proc. Natl. Acad. Sci. U.S.A. 104, 11730-11735.
50. Harrington, L. E., Janowski, K. M., Oliver, J. R., Zajac, A. J., and Weaver, C. T. (2008). Memory CD4 T cells emerge from effector T-cell progen-itors. Nature 452, 356-360.
51. Heeger, P. S., Greenspan, N. S., Kuhlen-Schmidt, S., Dejelo, C., Hricik, D. E., Schulak, J. A., and Tary-Lehmann, M.. (1999). Pretransplant fre-quency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 163, 2267-2275.
52. Hislop, A. D., Gudgeon, N. H., Callan, M. F., Fazou, C., Hasegawa, H., Salmon, M., and Rickinson, A. B. (2001). EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J. Immunol. 167, 2019-2029.
53. Huster, K. M., Busch, V., Schiemann, M., Linkemann, K., Kerksiek, K. M., Wagner, H., and Busch, D. H. (2004). Selective expression of IL-7 recep-tor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc. Natl. Acad. Sci. U.S.A. 101, 5610-5615.
54. Intlekofer, A. M., Takemoto, N., Kao, C., Banerjee, A., Schambach, F., Northrop, J. K., Shen, H., Wherry, E. J., and Reiner, S. L. (2007). Require-ment for T-bet in the aberrant dif-ferentiation of unhelped memory CD8+ T cells. J. Exp. Med. 204, 2015-2021.
55. Intlekofer,A. M., Takemoto, N.,Wherry, E. J., Longworth, S. A., Northrup, J. T., Palanivel, V. R., Mullen, A. C., Gasink, C. R., Kaech, S. M., Miller, J. D., Gapin, L., Ryan, K., Russ, A. P., Lindsten, T., Orange, J. S., Gol-Drath, A. W., Ahmed, R., and Reiner, S. L. (2005). Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6, 1236-1244.
56. Jones, N. D., Brook, M. O., Carvalho-Gaspar, M., Luo, S., and Wood, K. J. (2010). Regulatory T cells can prevent memory CD8+ T-cell-mediated rejection following poly-morphonuclear cell depletion. Eur. J. Immunol. 40, 3107-3116.
57. Joshi, N. S., Cui, W., Chandele, A., Lee, H. K.,Urso,D. R.,Hagman,J.,Gapin, L., and Kaech, S. M. (2007). Inflam-mation directs memory precursor and short-lived effector CD8(+)T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281-295.
58. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D., and Ahmed, R. (2003). Selective expres-sion of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191-1198.
59. Kalia, V., Sarkar, S., and Ahmed, R. (2008). Fine-tuning CD4+ cen-tral memory T cell heterogeneity by strength of stimulation. Eur. J. Immunol. 38, 15-19.
60. Kallies, A., Xin, A., Belz, G. T., and Nutt, S. L. (2009). Blimp-1 transcription factor is required for the differen-tiation of effector CD8(+)Tcells and memory responses. Immunity 31, 283-295.
61. Kawai, T., Abrahamian, G., Sogawa, H., Wee, S., Boskovic, S., Andrew, D., Nadazdin, O., Mauiyyedi, S., Wey-Mouth, D., Ko, D., Colvin, R., Sachs, D., and Cosimi, A. (2001a). Costim-ulatory blockade for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Transplant. Proc. 33, 221-222.
62. Kawai, T., Sogawa, H., Abrahamian, G., Boskovic, S., Wee, S. L., Nadazdin, O., Andrews, D., Ko, D., Mauiyyedi, S., Colvin, R. B., Sachs, D. H., and Cosimi, A. B. (2001b). Long-term results of CD154 blockade for induc-tion of mixed chimerism and kidney allograft tolerance in non-human primates. Am. J. Transplant. 1(Suppl. 1), 275.
63. Kawai, T., Cosimi, A. B., Colvin, R. B., Powelson, J., Eason, J., Kozlowski, T., Sykes, M., Monroy, R., Tanaka, M., and Sachs, D. H. (1995). Mixed allo-geneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59, 256-262.
64. Kawai, T., Poncelet, A., Sachs, D. H., Mauiyyedi, S., Boskovic, S., Wee, S. L., Ko, D. S., Bartholomew, A., Kimikawa, M., Hong, H. Z., Abra-Hamian, G., Colvin, R. B., and Cosimi, A. B. (1999a). Long-term outcome and alloantibody produc-tion in a non-myeloablative regi-men for induction of renal allo-graft tolerance. Transplantation 68, 1767-1775.
65. Kawai, T., Sachs, D. H., and Cosimi, A. B. (1999b). Tolerance to vascular-ized organ allografts in large-animal models. Curr. Opin. Immunol. 11, 516-520.
66. Kawai, T., Sogawa, H., Boskovic, S., Abrahamian, G., Smith, R. N., Wee, S. L., Andrews, D., Nadazdin, O., Koyama, I., Sykes, M., Winn, H. J., Colvin, R. B., Sachs, D. H., and Cosimi, A. B. (2004). CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhu-man primates. Am. J. Transplant. 4, 1391-1398.
67. Kean, L. S., Adams, A. B., Strobert, E., Hendrix, R., Gangappa, S Jones, T. R., Shirasugi, N., Rigby, M. R., Hamby, K., Jiang, J., Bello, H., Anderson, D., Cardona, K., Durham, M. M., Pearson, T. C., and Larsen, C. P. (2007). Induction of chimerism in rhesus macaques through stem cell trans-plant and costimulation blockade-based immunosuppression. Am. J. Transplant. 7, 320-335.
68. Kean, L. S., Gangappa, S., Pearson, T. C., and Larsen, C. P. (2006). Trans-plant tolerance in non-human pri-mates: progress, current challenges and unmet needs. Am. J. Transplant. 6, 884-893.
69. Khoury, S. J., Akalin, E., Chan-Draker, A., Turka, L., Linsley, P. S., Sayegh, M. H., and Hancock, W. W. (1995). CD28-B7 costimu-latory blockade by CTLA4-Ig pre-vents actively induced experiemen-tal autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous sys-tem. Immunol. J. 155, 4521-4524.
70. Kim, J. S., Lee, J. I., Shin, J. Y., Kim, S. Y., Shin, J. S., Lim, J. H., Cho, H. S., Yoon, I. H., Kim, K. H., Kim, S. J., and Park, C. G. (2009). Borte-zomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates. Transplantation 88, 1349-1359.
71. Kim, S. K., Schluns, K. S., and Lefran-Cois, L. (1999). Induction and visu-alization of mucosal memory CD8 T cells following systemic virus infec-tion. J. Immunol. 163, 4125-4132.
72. Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D., Fech-Ner, J. H., and Knechtle, S. J. (1997). CTLA4Ig and anti-CD40 ligand pre-vent renal allograft rejection in pri-mates. Proc. Natl. Acad. Sci. U.S.A. 94, 8789-8794.
73. Kitchens, W. H., Haridas, D., Wagener, M. E., Song, M., Kirk, A. D., Larsen, C. P., and Ford, M. L. (2011a). Inte-grin antagonists prevent costimu-latory blockade-resistant transplant rejection by CD8+ memory T cells. Am. J. Transplant. 12, 69-80.
74. Kitchens, W. H., Larsen, C. P., and Ford, M. L. (2011b). Integrin antagonists for transplant immunosuppression: panacea or peril? Immunotherapy 3, 305-307.
75. Koelle, D. M., Chen, H. B., McClurkan, C. M., and Petersdorf, E. W. (2002). Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. Blood 99, 3844-3847.
76. Koyama, I., Nadazdin, O., Boskovic, S., Ochiai, T., Smith, R. N., Sykes, M., Sogawa, H., Murakami, T., Strom, T. B., Colvin, R. B., Sachs, D. H., Benichou, G., Cosimi, A. B., and Kawai, T. (2007). Depletion of CD8 memory T cells for induction of tol-erance of a previously transplanted kidney allograft. Am. J. Transplant. 7, 1055-1061.
77. Kremer, J. M., Westhovens, R., Leon, M., Di Giorgio, E., Alten, R., Stein-feld, S., Russell, A., Dougados, M., Emery,P.,Nuamah,I. F.,Williams,G. R., Becker, J. C., Hagerty, D. T., and Moreland, L. W. (2003). Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349, 1907-1915.
78. Kuchroo, V. K., Martin, C. A., Greer, J. M., Ju, S. T., Sobel, R. A., and Dorf, M. E. (1993). Cytokines and adhesion molecules contribute to the ability of myelin prote-olipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151, 4371-4382.
79. Lacombe, M. H., Hardy, M. P., Rooney, J., and Labrecque, N. (2005). IL-7 receptor expression levels do not identify CD8+ memory T lym-phocyte precursors following pep-tide immunization. J. Immunol. 175, 4400-4407.
80. Landais, E., Romagnoli, P. A., Corper, A. L., Shires, J., Altman, J. D., Wil-Son, I. A., Garcia, K. C., and Teyton, L. (2009). New design of MHC class II tetramers to accommodate funda-mental principles of antigen presen-tation. J. Immunol. 183, 7949-7957.
81. Lanzavecchia, A., and Sallusto, F. (2000a). From synapses to immuno-logical memory: the role of sus-tained T cell stimulation. Curr. Opin. Immunol. 12, 92-98.
82. Lanzavecchia, A., and Sallusto, F. (2000b). Dynamics of T lympho-cyte responses: intermediates, effec-tors, and memory cells. Science 290, 92-97.
83. Larsen, C. P., Elwood, E. T., Alexan-Der, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Lins-Ley, P. S., Winn, K. J., and Pearson, T. C. (1996). Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438.
84. Larsen, C. P., Pearson, T. C., Adams, A. B., Tso, P., Shirasugi, N., Strobertm, E.,Anderson,D.,Cowan,S.,Price,K., Naemura, J., Emswiler, J., Greene, J., Turk, L. A., Bajorath, J., Townsend, R., Hagerty, D., Linsley, P. S., and Peach, R. J. (2005). Rational devel-opment of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am. J. Transplant. 5, 443-453.
85. Lechler, R., Batchelor, R., and Lombardi, G. (1991). The relationship between MHC restricted and allospecific T cell recognition. Immunol. Lett. 29, 41-50.
86. Li, X. C., and Turka, L. A. (2010). An update on regulatory T cells in trans-plant tolerance and rejection. Nat. Rev. Nephrol. 6, 577-583.
87. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M., Greene, J. L., Ledbetter, J. A., Singh, C., and Tepper, M. A. (1992). Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795.
88. Lo, D. J., Weaver, T. A., Stempora, L., Mehta, A. K., Ford, M. L., Larsen, C. P., and Kirk, A. D. (2011). Selec-tive targeting of human allorespon-sive CD8+ effector memory T cells based on CD2 expression. Am. J. Transplant. 11, 22-33.
89. Lohning, M., Hegazy, A. N., Pinschewer, D. D., Busse, D., Lang, K. S., Hofer, T., Radbruch, A., Zinkernagel, R. M., and Hengartner, H. (2008). Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J. Exp. Med. 205, 53-61.
90. Lombardi,G.,Sidhu,S.,Daly,M.,Batch-elor, J. R., Makgoba, W., and Lech-ler, R. I. (1990). Are primary allore-sponses truly primary? Int. Immunol. 2, 9-13.
91. London, C. A., Lodge, M. P., and Abbas, A. K. (2000). Functional responses and costimulator dependence of memory CD4+ T cells. J. Immunol. 164, 265-272.
92. Macdonald, W. A., Chen, Z., Gras, S., Archbold, J. K., Tynan, F. E., Clements,C. S.,Bharadwaj,M.,Kjer-Nielsen, L., Saunders, P. M., Wilce, M. C., Crawford, F., Stadinsky, B., Jackson, D., Brooks, A. G., Purcell, A. W., Kappler, J. W., Burrows, S. R., Rossjohn, J., and McCluskey, J. (2009). T cell allorecognition via molecular mimicry. Immunity 31, 897-908.
93. Macedo, C., Orkis, E. A., Popescu, I., Elinoff, B. D., Zeevi, A., Shapiro, R., Lakkis, F. G., and Metes, D. (2009). Contribution of naive and mem-ory T-cell populations to the human alloimmune response. Am. J. Trans-plant. 9, 2057-2066.
94. Marshall, H. D., Chandele, A., Jung, Y. W., Meng, H., Poholek, A. C., Parish, I. A., Rutishauser, R., Cui, W., Kle-instein, S. H., Craft, J., and Kaech, S. M. (2011). Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+)cellprop-erties during viral infection. Immu-nity 35, 633-646.
95. Marzo, A. L., Klonowski, K. D., Le Bon, A., Borrow, P., Tough, D. F., and Lefrancois, L. (2005). Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol. 6, 793-799.
96. Masopust, D., Ha, S. J., Vezys, V., and Ahmed, R. (2006). Stimulation his-tory dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J. Immunol. 177, 831-839.
97. Masopust, D., Vezys, V., Marzo, A. L., and Lefrancois, L. (2001). Preferen-tial localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417.
98. Minamimura, K., Sato, K., Yagita, H., Tanaka, T., Arii, S., and Maki, T. (2008). Strategies to induce marked prolongation of secondary skin allo-graft survival in alloantigen-primed mice. Am. J. Transplant. 8, 761-772.
99. Morris, G. P., and Allen, P. M. (2009). Cutting edge: highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease. J. Immunol. 182, 6639-6643.
100. Murali-Krishna, K., and Ahmed, R. (2000). Cutting edge: naive T cells masquerading as memory cells. J. Immunol. 165, 1733-1737.
101. Nadazdin, O., Boskovic, S., Murakami, T., O'Connor, D. H., Wiseman, R. W., Karl, J. A., Tuscher, J. J., Sachs, D. H., Madsen, J. C., Tocco, G., Kawai, T., Cosimi, A. B., and Beni-chou, G. (2010). Phenotype, distri-bution and alloreactive properties of memory T cells from cynomol-gus monkeys. Am. J. Transplant. 10, 1375-1384.
102. Nadazdin, O., Boskovic, S., Murakami, T., Tocco, G., Smith, R. N., Colvin, R. B., Sachs, D. H., Allan, J., Madsen, J. C.,Kawai,T.,Cosimi,A. B.,and Beni-chou, G. (2011). Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci. Transl. Med. 3, 86ra51
103. Ndejembi, M. P., Teijaro, J. R., Patke, D. S., Bingaman, A. W., Chandok, M. R., Azimzadeh, A., Nadler, S. G., and Farber, D. L. (2006). Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J. Immunol. 177, 7698-7706.
104. Neff, R. T., Hurst, F. P., Falta, E. M., Bohen, E. M., Lentine, K. L., Dharnidharka, V. R., Agodoa, L. Y., Jindal, R. M., Yuan, C. M., and Abbott, K. C. (2008). Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplan-tation 86, 1474-1478.
105. Nikolich-Zugich, J., Slifka, M. K., and Messaoudi, I. (2004). The many important facets of T-cell reper-toire diversity. Nat. Rev. Immunol. 4, 123-132.
106. Oberbarnscheidt, M. H., Ng, Y. H., and Chalasani, G. (2008). The roles of CD8 central and effector memory T-cell subsets in allograft rejection. Am. J. Transplant. 8, 1809-1818.
107. Ochiai, T., Benichou, G., Cosimi, A. B., and Kawai, T. (2007). Induction of allograft tolerance in nonhuman primates and humans. Front. Biosci. 12, 4248-4253.
108. Padovan, E., Casorati, G., Dellabona, P., Meyer, S., Brockhaus, M., and Lan-zavecchia, A. (1993). Expression of two T cell receptor alpha chains: dual receptor T cells. Science 262, 422-424.
109. Pantenburg, B., Heinzel, F., Das, L., Heeger, P. S., and Valujskikh, A. (2002). T cells primed by Leishma-nia major infection cross-react with alloantigens and alter the course of allograft rejection. J. Immunol. 169, 3686-3693.
110. Patel, S. R., Cadwell, C. M., Med-ford, A., and Zimring, J. C. (2009). Transfusion of minor histocompat-ibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J. Clin. Invest. 119, 2787-2794.
111. Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L. S., Jones, R. G., and Choi, Y. (2009). Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103-107.
112. Pearl, J. P., Parris, J., Hale, D. A., Hoff-mann,S. C.,Bernstein,W. B.,McCoy, K. L., Swanson, S. J., Mannon, R. B., Roederer, M., and Kirk, A. D. (2005). Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am. J. Transplant. 5, 465-474.
113. Pepper, M., Linehan, J. L., Pagan, A. J., Zell, T., Dileepan, T., Cleary, P. P., and Jenkins, M. K. (2010). Dif-ferent routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat. Immunol. 11, 83-89.
114. Pepper, M., Pagan, A. J., Igyarto, B. Z., Taylor, J. J., and Jenkins, M. K. (2011). Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector mem-ory cells. Immunity 35, 583-595.
115. Posselt, A. M., Bellin, M. D., Tavakol, M., Szot, G. L., Frassetto, L. A., Masharani, U., Kerlan, R. K., Fong, L., Vincenti, F. G., Hering, B. J., Bluestone, J. A., and Stock, P. G. (2010). Islet transplantation in type 1 diabetics using an immunosup-pressive protocol based on the anti-LFA-1 antibody efalizumab. Am. J. Transplant. 10, 1870-1880.
116. Rao, R. R., Li, Q., Odunsi, K., and Shrikant, P. A. (2010). The mTOR kinase determines effector versus memory CD8+ T cell fate by regulat-ing the expression of transcription factors T-bet and eomesodermin. Immunity 32, 67-78.
117. Roberts,A. D.,Ely,K. H.,andWoodland, D. L. (2005). Differential contribu-tions of central and effector memory T cells to recall responses. J. Exp. Med. 202, 123-133.
118. Rutishauser, R. L., Martins, G. A., Kalachikov, S., Chandele, A., Parish, I. A., Meffre, E., Jacob, J., Calame, K., and Kaech, S. M. (2009). Transcrip-tional repressor Blimp-1 promotes CD8(+) T cell terminal differenti-ation and represses the acquisition of central memory T cell properties. Immunity 31, 296-308.
119. Sallusto, F., Geginat, J., and Lanzavec-Chia,A. (2004). Central memory and effector memory T cell subsets: func-tion, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763.
120. Sallusto, F., Lenig, D., Forster, R., Lipp, M., and Lanzavecchia, A. (1999). Two subsets of memory T lympho-cytes with distinct homing potentials and effector functions. Nature 401, 708-712.
121. Sarkar, J. K., Mitra, A. C., and Mukher-Jee, M. K. (1975). The minimum protective level of antibodies in smallpox. Bull. World Health Organ. 52, 307-311.
122. Sarkar, S., Kalia, V., Haining, W. N., Konieczny, B. T., Subramaniam, S., and Ahmed, R. (2008). Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625-640.
123. Schenk, A. D., Gorbacheva, V., Rabant, M., Fairchild, R. L., and Valujskikh, A. (2009). Effector functions of donor-reactive CD8 memory T cells are dependent on ICOS induced during division in cardiac grafts. Am. J. Transplant. 9, 64-73.
124. Schenk, A. D., Nozaki, T., Rabant, M., Valujskikh, A., and Fairchild, R. L. (2008). Donor-reactive CD8 mem-ory T cells infiltrate cardiac allo-grafts within 24-h posttransplant in naive recipients. Am. J. Transplant. 8, 1652-1661.
125. Seder, R. A., Darrah, P. A., and Roed-Erer, M. (2008). T-cell quality in memory and protection: implica-tions for vaccine design. Nat. Rev. Immunol. 8, 247-258.
126. Sener, A., Tang, A. L., and Farber, D. L. (2009). Memory T-cell predom-inance following T-cell depletional therapy derives from homeostatic expansion of naive T cells. Am. J. Transplant. 9, 2615-2623.
127. Setoguchi, K., Schenk, A., Ishii, D., Tanabe, K., and Fairchild, R. L. (2009). Anti-lymphocyte function-associated antigen-1 (LFA-1) mon-oclonal antibody prevents graft-infiltrating CD8 memory T cells early post-transplant. Am. J. Trans-plant. 9, 209.
128. Shin, H., Blackburn, S. D., Intlekofer, A. M., Kao, C., Angelosanto, J. M., Reiner, S. L., and Wherry, E. J. (2009). A role for the transcriptional repressor Blimp-1 in CD8(+)T cell exhaustion during chronic viral infection. Immunity 31, 309-320.
129. Sloan-Lancaster, J., and Allen, P. M. (1996). Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14, 1-27.
130. Sprent, J., Cho, J. H., Boyman, O., and Surh, C. D. (2008). T cell homeosta-sis. Immunol. Cell Biol. 86, 312-319.
131. Stapler, D., Lee, E. D., Selvaraj, S. A., Evans, A. G., Kean, L. S., Speck, S. H., Larsen, C. P., and Gangappa, S. (2008). Expansion of effector mem-ory TCR V{beta}4+CD8+ Tcells is associated with latent infection-mediated resistance to transplan-tation tolerance. J. Immunol. 180, 3190-3200.
132. Suresh, M., Whitmire, J. K., Harring-Ton, L. E., Larsen, C. P., Pearson, T. C., Altman, J. D., and Ahmed, R. (2001). Role of CD28-B7 interac-tions in generation and maintenance of CD8 T cell memory. J. Immunol. 167, 5565-5573.
133. Sykes, M. (2001). Mixed chimerism and transplant tolerance. Immunity 14, 417-424.
134. Sykes, M., and Sachs, D. H. (1988). Mixed allogeneic chimerism as an approach to transplantation toler-ance. Immunol. Today 9, 23-27.
135. Sykes, M., Szot, G. L., Swenson, K. A., and Pearson, D. A. (1997). Induction of high levels of allo-geneic hematopoietic reconstitution and donor-specific tolerance with-out myelosuppressive conditioning. Nat. Med. 3, 783-787.
136. Theien, B. E.,Vanderlugt, C. L., Eagar, T. N., Nickerson-Nutter, C., Nazareno, R., Kuchroo, V. K., and Miller, S. D. (2001). Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 107, 995-1006.
137. Thomson, A. W., Turnquist, H. R., and Raimondi, G. (2009). Immunoreg-ulatory functions of mTOR inhibi-tion. Nat. Rev. Immunol. 9, 324-337.
138. Turgeon, N. A., Avila, J. G., Cano, J. A., Hutchinson, J. J., Badell, I. R., Page, A. J., Adams, A. B., Sears, M. H., Bowen, P. H., Kirk, A. D., Pear-son, T. C., and Larsen, C. P. (2010). Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am. J. Transplant. 10, 2082-2091.
139. Umetsu, D. T., Yunis, E. J., Matsui, Y., Jabara, H. H., and Geha, R. S. (1985). HLA-DR-4-associated alloreactivity of an HLA-DR-3-restricted human tetanus toxoid-specific T cell clone: inhibition of both reactivities by an alloantiserum. Eur. J. Immunol. 15, 356-361.
140. Valujskikh, A., Pantenburg, B., and Heeger, P. S. (2002). Primed allospe-cific T cells prevent the effects of cos-timulatory blockade on prolonged cardiac allograft survival in mice. Am. J. Transplant. 2, 501-509.
141. van Halteren, A. G., Jankowska-Gan, E., Joosten, A., Blokland, E., Pool, J., Brand, A., Burlingham, W. J., and Goulmy, E. (2009). Naturally acquired tolerance and sensitization to minor histocompatibility anti-gens in healthy family members. Blood 114, 2263-2272.
142. Vincenti, F., Charpentier, B., Van-Renterghem, Y., Rostaing, L., Bres-nahan, B., Darji, P., Massari, P., Mondragon-Ramirez, G. A., Agar-wal, M., Russo, G. D., Lin, C.-S., Garg, P., and Larsen, C. P. (2010). A phase III study of belatacept-based immunosuppression regimens ver-sus cyclosporine in renal transplant recipients (BENEFIT study). Am. J. Transplant. 10, 535-546.
143. Vincenti, F., Larsen, C., Durrbach, A., Wekerle, T., Nashan, B., Blancho, G., Lang, P., Grinyo, J., Halloran, P. F., Solez, K., Hagerty, D., Levy, E., Zhou, W., Natarajan, K., and Charpentier, B. (2005). Costimulation blockade with belatacept in renal transplanta-tion. N.Engl.J.Med.353, 770-781.
144. Vincenti, F., Mendez, R., Pescovitz, M., Rajagopalan, P. R., Wilkinson, A. H., Butt, K., Laskow, D., Slakey, D. P., Lorber, M. I., Garg, J. P., and Garovoy, M. (2007). A phase I/II randomized open-label multi-center trial of efalizumab, a human-ized anti-CD11a, anti-LFA-1 in renal transplantation. Am. J. Transplant. 7, 1770-1777
145. Vu, M. D., Clarkson, M. R., Yagita, H., Turka, L. A., Sayegh, M. H., and Li, X. C. (2006). Critical, but condi-tional, role of OX40 in memory T cell-mediated rejection. J. Immunol. 176, 1394-1401.
146. Wang, T., Ahmed, E. B., Chen, L., Xu, J., Tao,J.,Wang,C. R.,Alegre,M. L.,and Chong, A. S. (2010). Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allo-graft model. Am. J. Transplant. 10, 1524-1533.
147. Wang, T., Chen, L., Ahmed, E., Ma, L., Yin, D., Zhou, P., Shen, J., Xu, H., Wang, C. R., Alegre, M. L., and Chong, A. S. (2008). Prevention of allograft tolerance by bacterial infec-tion with Listeria monocytogenes. J. Immunol. 180, 5991-5999.
148. Weaver, T. A., Charafeddine, A. H., Agarwal, A., Turner, A. P., Russell, M., Leopardi, F. V., Kampen, R. L., Stempora, L., Song, M., Larsen, C. P., and Kirk, A. D. (2009). Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. Nat. Med. 15, 746-749.
149. Welsh, R. M. (2009). Blimp hovers over T cell immunity. Immunity 31, 178-180.
150. Wherry, E. J., and Ahmed, R. (2004). Memory CD8 T-cell differentiation during viral infection. J. Virol. 78, 5535-5545.
151. Wherry, E. J., Teichgraber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., and Ahmed, R. (2003). Lineage relation-ship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225-234.
152. Williams, M. A., Onami, T. M., Adams, A. B., Durham, M. M., Pearson, T. C., Ahmed, R., and Larsen, C. P. (2002). Cutting edge: persistent viral infection prevents tolerance induc-tion and escapes immune control following CD28/CD40 blockade-based regimen. J. Immunol. 169, 5387-5391.
153. Williams, M. A., Tan, J. T., Adams, A. B., Durham, M. M., Shirasugi, N., Whitmire, J. K., Harrington, L. E., Ahmed, R., Pearson, T. C., and Larsen, C. P. (2001). Characteriza-tion of virus-mediated inhibition of mixed chimerism and allospe-cific tolerance. J. Immunol. 167, 4987-4995.
154. Wojciechowski, S., Jordan, M. B., Zhu, Y., White, J., Zajac, A. J., and Hilde-Man, D. A. (2006). Bim medi-ates apoptosis of CD127(lo) effec-tor T cells and limits T cell memory. Eur. J. Immunol. 36, 1694-1706.
155. Woodland, D. L., and Kohlmeier, J. E. (2009). Migration, maintenance and recall of memory T cells in peripheral tissues. Nat. Rev. Immunol. 9, 153-161.
156. Wu, Z., Bensinger, S. J., Zhang, J., Chen, C., Yuan, X., Huang, X., Markmann, J. F., Kassaee, A., Rosengard, B. R., Hancock, W. W., Sayegh, M. H., and Turka, L. A. (2004). Homeostatic proliferation is a barrier to trans-plantation tolerance. Nat. Med. 10, 87-92.
157. Yamada, A., Salama, A. D., Sho, M., Najafian, N., Ito, T., Forman, J. P., Kewalramani, R., Sandner, S., Harada, H., Clarkson, M. R., Man-Delbrot,D.A.,Sharpe,A. H.,Oshima, H., Yagita, H., Chalasani, G., Lakkis, F. G., Auchincloss, H. Jr., and Sayegh, M. H. (2005). CD70 signal-ing is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J. Immunol. 174, 1357-1364.
158. Yang, J., Brook, M. O., Carvalho-Gaspar, M., Zhang, J., Ramon, H. E., Sayegh, M. H., Wood, K. J., Turka, L. A., and Jones, N. D. (2007). Allograft rejec-tion mediated by memory T cells is resistant to regulation. Proc. Natl. Acad. Sci. U.S.A. 104, 19954-19959.
159. Yang, Y., Xu, J., Niu, Y., Bromberg, J. S., and Ding, Y. (2008). T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. J. Immunol. 181, 8700-8710.
160. Zhai, Y., Meng, L., Gao, F., Busut-Til, R. W., and Kupiec-Weglinski, J. W. (2002). Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: thera-peutic implications for sensitized transplant recipients. J. Immunol. 169, 4667-4673.
161. Zhang, X., Sun, S., Hwang, I., Tough, D. F., and Sprent, J. (1998). Potent and selective stimulation of memory-phenotype CD8+ Tcells in vivo by IL-15. Immunity 8, 591-599.